New Frontiers: Precision Medicine a ‘Unique Signature’ for Pediatric Cancer Patients

Precision medicine, also known as personalized medicine, has revolutionized how physicians and scientists treat and study disease. According to Theodore Laetsch, MD, an oncologist at Children’s Hospital of Philadelphia, this ability to track and tailor individual patients’ unique genetic signatures has the most transformative potential in pediatric cancer. In this episode of Bench to Bedside, Dr. Laetsch shares how his new Frontier Program, the Center for Precision Medicine for High-risk Pediatric Cancer, harnesses advanced technologies and a growing multi omics database to optimize outcomes for childhood cancer patients.